Drug safety: FDA's future inspection plans need to address issues presented by COVID-19 backlog : testimony before the Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, Committee on Appropriations, House of Representatives / / statement of Mary Denigan-Macauley

• Pubblicazione: [Washington, D.C.] : , : United States Government Accountability Office, , 2021
• Descrizione fisica: 1 online resource (18 pages) : color illustrations, color map
• Soggetto topico: COVID-19 (Disease) - Treatment - United States; COVID-19 Pandemic, 2020- - United States; Drugs - Inspection - United States; Drugs - United States - Safety measures; Drug reimportation - United States
• Persona (resp. second.): Denigan-MacauleyMary
• Note generali: "For release on delivery, expected at 10:00 a.m. ET, Thursday, March 4, 2021."
• Nota di bibliografia: Includes bibliographical references.
• Altri titoli varianti: Drug safety
• Titolo autorizzato: Drug safety: FDA's future inspection plans need to address issues presented by COVID-19 backlog
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910715327503321
• Lo trovi qui: Univ. Federico II